A detailed history of Invst, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Invst, LLC holds 2,222 shares of ABT stock, worth $284,260. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,222
Previous 2,170 2.4%
Holding current value
$284,260
Previous $225,000 12.44%
% of portfolio
0.03%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 19, 2024

BUY
$100.07 - $118.13 $5,203 - $6,142
52 Added 2.4%
2,222 $253,000
Q2 2024

Aug 16, 2024

BUY
$100.73 - $112.44 $6,345 - $7,083
63 Added 2.99%
2,170 $225,000
Q1 2024

May 24, 2024

SELL
$109.52 - $120.96 $1,204 - $1,330
-11 Reduced 0.52%
2,107 $239,000
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $191,022 - $233,827
2,118 New
2,118 $233,000
Q2 2023

Jul 28, 2023

BUY
$100.78 - $112.29 $5,341 - $5,951
53 Added 2.72%
2,003 $218,000
Q1 2023

Apr 28, 2023

SELL
$96.86 - $114.01 $8,717 - $10,260
-90 Reduced 4.41%
1,950 $197,000
Q4 2022

Feb 01, 2023

SELL
$95.06 - $111.52 $5,418 - $6,356
-57 Reduced 2.72%
2,040 $224,000
Q3 2022

Nov 23, 2022

SELL
$96.76 - $112.03 $7,934 - $9,186
-82 Reduced 3.76%
2,097 $212,000
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $4,184 - $5,058
-41 Reduced 1.85%
2,179 $240,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $68,982 - $84,119
-605 Reduced 21.42%
2,220 $238,000
Q4 2021

Feb 25, 2022

BUY
$115.53 - $141.46 $16,867 - $20,653
146 Added 5.45%
2,825 $331,000
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $64,279 - $71,112
551 Added 25.89%
2,679 $316,000
Q2 2021

Jul 19, 2021

SELL
$105.79 - $124.53 $3,385 - $3,984
-32 Reduced 1.48%
2,128 $250,000
Q1 2021

Jun 23, 2021

BUY
$108.84 - $128.23 $21,441 - $25,261
197 Added 10.04%
2,160 $259,000
Q4 2020

Jun 23, 2021

BUY
$105.0 - $114.42 $206,115 - $224,606
1,963 New
1,963 $215,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Invst, LLC Portfolio

Follow Invst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.